Stig Ejdrup Andersen

Stig Ejdrup Andersen serves as a Clinical Associate Professor in the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. His academic base is in Clinical Pharmacology, with research conducted at Blegdamsvej 3 in Copenhagen.

His research spans critical areas of modern pharmacology including pharmacogenetics (CYP2D6 and DPYD variants), pharmacovigilance (machine learning applications in drug safety), psychopharmacology (QT prolongation risks, glaucoma interactions), and oncology pharmacology (DPD deficiency screening). His work bridges clinical practice with data science, particularly through collaborations with researchers like Brunak and Kaas-Hansen on large-scale prescription analysis.

Recent publications demonstrate strong focus on

• Risk assessment of antipsychotic cardiac effects
• Implementation of pharmacogenomic testing in oncology
• Drug interaction prevalence in Danish healthcare
• Thyroid disorder management during pregnancy

His research has garnered significant attention with policy references and news coverage, particularly in pharmacogenomics implementation.

As a Clinical Pharmacology specialist, Andersen maintains active clinical connections while contributing to academic knowledge through 37 research outputs including journal articles, reviews, and methodological studies. His work appears in journals spanning pharmacology, oncology, and psychiatry domains.